Ironwood Pharmaceuticals (IRWD) Earnings Date, Estimates & Call Transcripts $4.21 +0.10 (+2.43%) (As of 11/15/2024 ET) Add Compare Share Share Earnings Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrends Ironwood Pharmaceuticals Latest Earnings SummaryUpcoming Q4 Earnings DateFeb. 20EstimatedActual EPS (Nov. 7) $0.02 Missed By -$0.07 Consensus EPS (Nov. 7) $0.09 Ironwood Pharmaceuticals released Q3 2024 earnings on November 7, 2024, reporting an EPS of $0.02, which missed analysts' consensus estimates of $0.09 by $0.07. Quarterly revenue fell 19.4% year-over-year to $91.60 million, above the consensus estimate of $91.22 million. With a trailing EPS of -$0.03, Ironwood Pharmaceuticals' earnings are expected to grow 110.00% next year, from $0.10 to $0.21 per share. Conference Call TranscriptConference Call AudioEarnings Press ReleaseEarnings Slide DeckIRWD Upcoming EarningsIronwood Pharmaceuticals' next earnings date is estimated for Thursday, February 20, 2025, based off prior year's reporting schedules. Get Ironwood Pharmaceuticals Earnings Alerts Want to stay updated on the latest earnings announcements and upcoming reports? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Ironwood Pharmaceuticals and other key companies, straight to your inbox. Enter your email to sign up for newsletter Sign Up Skip Charts & View Estimated and Actual Earnings DataIRWD Earnings Estimates and Actuals by QuarterEarnings Estimates and Acutals by Quarter Chart DescriptionThe chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.IRWD Estimated and Actual Revenue by QuarterEstimated Revenue and Actual Revenue by Quarter Chart DescriptionThe chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter. Ad Crypto Swap Profits[625,000% Gain] – Are You Ready for the Next Altcoin Boom?All of our key indicators are flashing the same signal: an altcoin season is fast approaching. And if you know anything about crypto, you know that altcoin seasons are where some of the biggest gains happen.Register for the FREE Workshop Now & get $10 in Bitcoin Ironwood Pharmaceuticals Analyst EPS EstimatesQuarterNumber of EstimatesLow EstimateHigh EstimateAverage EstimateQ1 20242$0.14$0.18$0.16Q2 20242$0.14$0.17$0.16Q3 20243$0.03$0.16$0.11Q4 20243$0.08$0.17$0.12FY 202410$0.39$0.68$0.55Q1 20252$0.03$0.03$0.03Q2 20252$0.03$0.05$0.04Q3 20252$0.05$0.06$0.06Q4 20252$0.05$0.06$0.06FY 20258$0.16$0.20$0.18Q1 20261$0.08$0.08$0.08Q2 20261$0.09$0.09$0.09 Ironwood Pharmaceuticals Earnings History by Quarter Custom Range 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years 5 Years 10 Years Time Frame * Start Date * End Date Export to Excel DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueLinks 2/20/2025(Estimated)------- 11/7/2024Q3 2024$0.09$0.02 -$0.07$0.02$91.22M$91.60M 5/9/2024Q1 2024$0.18-$0.02 -$0.20-$0.01$105.75M$74.90M 11/9/2023Q3 2023$0.17$0.12 -$0.05$0.15$112.90M$113.74M 8/8/2023Q2 2023$0.25$0.31+$0.06$7.46$103.46M$107.38M 5/4/2023Q1 2023$0.24$0.25+$0.01$0.25$100.60M$104.06M 2/16/2023Q4 2022$0.28$0.27 -$0.01$0.27$108.23M$107.20M Get the Latest News and Ratings for IRWD and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Ironwood Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. Ironwood Pharmaceuticals Earnings - Frequently Asked Questions When is Ironwood Pharmaceuticals's earnings date? Ironwood Pharmaceuticals has not confirmed its next earnings publication date, but the company's estimated earnings date is Thursday, February 20th, 2025 based off last year's report dates. Learn more on IRWD's earnings history. What guidance has Ironwood Pharmaceuticals issued on next quarter's earnings? Ironwood Pharmaceuticals updated its FY 2024 earnings guidance on Thursday, November, 7th. The company issued revenue guidance of $350.0 million-$375.0 million, compared to the consensus revenue estimate of $357.2 million. Did Ironwood Pharmaceuticals beat their earnings estimates last quarter? In the previous quarter, Ironwood Pharmaceuticals (NASDAQ:IRWD) missed the analysts' consensus estimate of $0.09 by $0.07 with a reported earnings per share (EPS) of $0.02. Learn more on analysts' earnings estimate vs. IRWD's actual earnings. How can I listen to Ironwood Pharmaceuticals's earnings conference call? The conference call for Ironwood Pharmaceuticals's latest earnings report can be listened to online. Listen to Conference Call How can I read Ironwood Pharmaceuticals's conference call transcript? The conference call transcript for Ironwood Pharmaceuticals's latest earnings report can be read online. Read Transcript How much revenue does Ironwood Pharmaceuticals generate each year? Ironwood Pharmaceuticals (NASDAQ:IRWD) has a recorded annual revenue of $442.73 million. How much profit does Ironwood Pharmaceuticals generate each year? Ironwood Pharmaceuticals (NASDAQ:IRWD) has a recorded net income of -$1.00 billion. IRWD has generated -$0.03 earnings per share over the last four quarters. What is Ironwood Pharmaceuticals's EPS forecast for next year? Ironwood Pharmaceuticals's earnings are expected to grow from $0.10 per share to $0.21 per share in the next year, which is a 110.00% increase. ` More Earnings Resources from MarketBeat Related Companies IGM Biosciences Earnings Date Cryoport Earnings Date Zentalis Pharmaceuticals Earnings Date Kura Oncology Earnings Date Geron Earnings Date Ligand Pharmaceuticals Earnings Date MannKind Earnings Date Celldex Therapeutics Earnings Date Myriad Genetics Earnings Date Dynavax Technologies Earnings Date Earnings Tools Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Newsletter Earnings Call Transcripts Earnings Beats & Misses Corporate Guidance Earnings Screener Earnings By Country U.S. Earnings Reports Canadian Earnings Reports U.K. Earnings Reports Latest Articles MercadoLibre Down 23% After Missed Earnings: Time to Buy the Dip?Roblox Stock Soars 22% After Q3 Earnings – A Turning Point Ahead?Apple Earnings - When Really Good Just Isn’t Good Enough Roblox Stock Set for More Gains After Strong Earnings ReportAmazon: Why Analysts Think It's a Solid Buy Ahead of EarningsLam Research Proves Analysts Wrong with a Strong Earnings ReportPulteGroup Earnings Signal Potential Entry Points for Investors [625,000% Gain] – Are You Ready for the Next Altcoin Boom? (Ad)All of our key indicators are flashing the same signal: an altcoin season is fast approaching. And if you know anything about crypto, you know that altcoin seasons are where some of the biggest gains happen.Register for the FREE Workshop Now & get $10 in Bitcoin This page (NASDAQ:IRWD) was last updated on 11/17/2024 by MarketBeat.com Staff From Our PartnersTrump’s IRS Hands Massive ‘Victory Gift’ To 401K OwnersThe "Fake Media" has completely ignored Trump's genius "victory gift" to all America First patriots like you. ...Colonial Metals | SponsoredUnveiled: NVIDIA’s "Secret Royalty" ProgramDid you know that there's an investment that will give you the opportunity to collect "royalties" every time N...Behind the Markets | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Ironwood Pharmaceuticals, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Ironwood Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
